A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis‐I or Plexiform Neurofibromas

Documenti analoghi

• Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling
  di: Marija Kekic, et al.
  Pubblicazione: (2026)
• Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD
  di: Sahira Chaiben, et al.
  Pubblicazione: (2025)
• Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis
  di: Stefan P. H. van den Berg, et al.
  Pubblicazione: (2025)
• Neural Controlled Differential Equation and Its Application in Pharmacokinetics and Pharmacodynamics
  di: Zhisong Wu, et al.
  Pubblicazione: (2025)
• Pharmacokinetics‐Based Design of Subcutaneous Controlled Release Systems for Biologics
  di: Abigail K. Grosskopf, et al.
  Pubblicazione: (2025)